Data / Form D filings / Vicora, Inc.
Vicora, Inc.: Form D filings
Vicora, Inc., a biotechnology company in Buffalo, NY, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on September 18, 2026, reports $2.3 million sold of a $2.5 million offering to 59 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 665 NORTHLAND AVENUE, Buffalo, NY, 14211
- Phone
- (716) 536-2971
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2091847
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | New notice | $2,500,000 | $2,300,000 | $200,000 | 59 | Apr 1, 2026 | sec.gov |
| Oct 20, 2025 | New notice | $6,000,000 | $3,400,000 | $2,600,000 | 55 | Jan 31, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matthew Colpoys | Executive Officer, Director | |
| Shawn Patterson | Executive Officer | |
| William Maggio | Director | |
| Richard Ducharme | Executive Officer, Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Sep 14, 2026 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vicora, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.